| Catalog Number | YR1335 |
| Alias | 科研级 Diridavumab ( 地利伏单抗 ), Anti-Influenza A Virus Hemagglutinin HA2 Subunit from Various Strains Recombinant Antibody, Research Grade Diridavumab |
| Size | 1mg, 5mg |
| Molecular Name | Diridavumab |
| CAS Number | 1393659-46-5 |
| Target | Influenza A Virus Hemagglutinin HA2 Subunit from Various Strains[Influenza A Virus] |
| Antibody Isotype | IgG1 Lambda |
| Clonity | Monoclonal |
| Concentration | 1mg/ml |
| Purity | >95% as determined by SDS-PAGE |
| Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Formulation | PBS, pH7.5 |
| Shipping Condition | Shipped on ice packs. |
| Background | Diridavumab (CR6261) (INN) is a monoclonal antibody designed for the treatment of influenza A. This drug was developed by Janssen Pharmaceutical Companies of Johnson & Johnson. |
| Application | FCM |
| Remarks | This product is for research use only. |
销售微信
官方公众号
0
